HUCOP Clinical Pharmacy Rounds - Novel Oral Therapies for the Management of Thrombocytopenia of Chronic Liver Disease


Date: Jun 11, 2019 12:00 PM - 01:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Jun 18, 2019 10:30 PM

Activity Type

Knowledge

Target Audience(s)

Pharmacists
Faculty
Residents
Fellows
Students

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Registration Closed  

Objectives

  • Explain the Background information as pertains to thrombocytopenia of chronic liver disease
  • Describe the standard of care for the preoperative management of patients with thrombocytopenia who are undergoing elective invasive surgical procedures
  • Outline supporting evidence for the FDA's recently approved novel therapies for management of chronic liver disease patients with thromobocytopenia who are undergoing elective invasive surgical procedures
  • List the perioperative role of pharmacists in the care of patients with thrombocytopenia of chronic liver disease

Speaker(s)/Author(s)

Dr. James Onayiga, PharmD, B.Sc.
PGY-1 Resident

Activity Number

0010-9999-19-023-L01-P
Date: 06/11/19
Time: 12:00 PM - 01:00 PM

CE Hours

1.00

Location

HUCOP Annex III Classroom 117
Registration Closed